Market Place
Sourcing Support
Vyome Shows VT-1908 Effectively Treats Uveitis, Opens $3B Market
17 Sep 2025 //
BUSINESSWIRE
Vyome Inks MoU with India`s Top Medical Device Studio, Embryyo
21 Aug 2025 //
BUSINESSWIRE
Vyome Announces Strategic Review of Livechain
18 Aug 2025 //
BUSINESSWIRE
Vyome to Mark First Day of Nasdaq Trading as HIND
15 Aug 2025 //
BUSINESSWIRE
Vyome Closes Merger, To Trade on Nasdaq as HIND Tomorrow
14 Aug 2025 //
BUSINESSWIRE
Vyome Merges with ReShape Lifescience, Approved by Nasdaq as HIND
13 Aug 2025 //
BUSINESSWIRE
Vyome Reveals New Board with Strong MIT and AI Connections
12 Aug 2025 //
BUSINESSWIRE
ReShape Lifesciences, Vyome Merger Wins Shareholder Approval
07 Aug 2025 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.